Literature DB >> 17512076

Influence of fillers in powder formulations containing N-acetyl-L-cysteine on nasal peptide absorption.

Takahiro Matsuyama1, Takahiro Morita, Yuji Horikiri, Hiroshi Yamahara, Hiroyuki Yoshino.   

Abstract

We examined the influence of filler species on the nasal absorbability of peptide drugs via a newly developed powdery formulation system containing N-acetyl-l-cysteine (NAC) as an absorption enhancer. Using salmon calcitonin (SCT) as the principal model drug, we tested the effects of various formulations with different powder materials as fillers on the nasal absorption of SCT in rats. An intranasal administration experiment revealed that the use of less wettable powders provided better nasal absorbability, and the highest absolute bioavailability (30.0% +/- 8.6%) was obtained when ethylcellulose was used as a filler. All these results were readily explicable in terms of our hypothetical enhancing mechanism. Furthermore, human parathyroid hormone and insulin were applied to this ethylcellulose formulation system, giving nasal bioavailabilities of 28.2% +/- 6.5% and 23.4% +/- 10.6%, respectively, thus suggesting that this formulation system is widely applicable to peptide drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512076     DOI: 10.1016/j.jconrel.2007.04.006

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  3 in total

1.  Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers.

Authors:  M R Lofwall; D E Moody; W B Fang; P A Nuzzo; S L Walsh
Journal:  J Clin Pharmacol       Date:  2011-05-24       Impact factor: 3.126

2.  Impaired airway mucociliary function reduces antigen-specific IgA immune response to immunization with a claudin-4-targeting nasal vaccine in mice.

Authors:  Hidehiko Suzuki; Takahiro Nagatake; Ayaka Nasu; Huangwenxian Lan; Koji Ikegami; Mitsutoshi Setou; Yoko Hamazaki; Hiroshi Kiyono; Kiyohito Yagi; Masuo Kondoh; Jun Kunisawa
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

3.  Pharmacokinetics, tolerability, and safety of intranasal administration of reformulated OxyContin(®) tablets compared with original OxyContin (®) tablets in healthy adults.

Authors:  Peter J Perrino; Salvatore V Colucci; Glen Apseloff; Stephen C Harris
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.